• Users Online: 76
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2020  |  Volume : 8  |  Issue : 4  |  Page : 71-73

Assessment of microsphere-controlled drug delivery for local control of tooth movement


1 Department of Orthodontics and Dentifacial Orthopedics, Meghna Institute of Dental Sciences, Nizamabad, Telangana, India
2 Department of Orthodontics and Dentifacial Orthopedics, Govt. Dental College and Hospital, Hyderabad, Telangana, India
3 Department of Orthodontics and Dentifacial Orthopedics, GITAMS Dental College and Hospital, Visakhapatnam, Andhra Pradesh, India
4 Department of Orthodontics, Meghna Institute of Dental Sciences, Nizamabad, Telangana, India
5 Depatment of Periodontics, Meghna Institute of Dental Sciences, Nizamabad, Telangana, India

Correspondence Address:
Dr. Malledi Narasimha Lakshmi
Department of Orthodontics and Dentifacial Orthopedics, Govt. Dental College and Hospital, Afzalgunj Rd, near Police Station, Afzal Gunj, Hyderabad 500012, Telangana.
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/INJO.INJO_39_20

Rights and Permissions

Background: Orthodontics is a special discipline dedicated to the investigation and practice of moving teeth through the bone. This study was conducted to assess new methods to locally enhance orthodontic anchorage. Materials and Methods: A single injection of 1 mg/kg nonencapsulated or microsphere encapsulated osteoprotegerin (OPG) was delivered into the palatal mucosa mesial to the first maxillary molar 1 day prior to tooth movement. A positive control group received injections of 5 mg/kg nonencapsulated OPG every 3 days during tooth movement. After 28 days of tooth movement, hemi-maxillae and femurs were dissected. Molar mesial and incisor distal tooth movement was measured using stone casts that were scanned and magnified. Results: Maximum movement was obtained with an empty microsphere single injection as compared to 1 mg/kg nonencapsulated OPG, 1 mg/kg encapsulated OPG, and 5 mg/kg nonencapsulated OPG. Maximum movement 2.6 mm was obtained with an empty microsphere single injection as compared to 1 mg/kg nonencapsulated OPG (2.4 mm), 1 mg/kg encapsulated OPG (2.5 mm), and 5 mg/kg nonencapsulated OPG (1.2 mm). A significant difference was found in bone mineral content, bone mineral density, tissue mineral content, and tissue mineral density with encapsulated and encapsulated OPG and microspheres (P < 0.05). Conclusion: Authors found that microsphere encapsulation of OPG allows for controlled drug release and enhances site-specific orthodontic anchorage without systemic side effects.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1113    
    Printed53    
    Emailed0    
    PDF Downloaded75    
    Comments [Add]    

Recommend this journal